ArticlebioRxiv : the preprint server for biology2024

Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression.

Sean P Rinella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.